Searched over 200M research papers
5 papers analyzed
These studies suggest that certain natural extracts like Swertia chirayita can lower blood sugar levels, while genetic factors and sugar intake are linked to diabetes and hypertension risks.
20 papers analyzed
A study involving 82 hospitalized patients revealed that the mean blood sugar level during hospitalization was 228.3 mg/100 ml, with a significant number of patients exhibiting blood sugar levels above 250 mg/100 ml. This high threshold was chosen to investigate the correlation between hyperglycemia and vascular damage. The study found no significant connection between blood sugar levels and dietary treatment, suggesting that strict diets alone may not effectively control blood sugar levels in patients with juvenile diabetes.
A systematic review and meta-analysis examined the relationship between sugar intake and hypertension. The analysis included 35 studies and found that sugar-sweetened beverages (SSBs) and artificially sweetened beverages (ASBs) were positively associated with an increased risk of hypertension. Specifically, a 250-g/day increment in SSBs was linked to a significant rise in systolic blood pressure (SBP) and diastolic blood pressure (DBP). This evidence underscores the harmful effects of high sugar intake on blood pressure levels, particularly from SSBs and ASBs.
Research on the blood sugar-lowering effects of Swertia chirayita in albino rats demonstrated that a 250 mg/kg dose of the hexane fraction of the plant significantly reduced blood sugar levels. This effect was observed in fed, glucose-loaded, and tolbutamide-pretreated animal models, but not in fasted rats. This suggests that Swertia chirayita may have potential as a natural remedy for managing blood sugar levels in certain conditions.
In a study of premature infants, glucose infusions that raised blood sugar levels above 250 mg/100 ml resulted in only a slight increase in serum insulin levels. However, the infusion of essential amino acids led to a significant spike in serum insulin, indicating that amino acids might play a crucial role in insulin regulation in premature infants. This finding highlights the complexity of insulin response mechanisms in early life.
The G-250A promoter polymorphism of the hepatic lipase gene (LIPC) has been identified as a predictor for the conversion from impaired glucose tolerance (IGT) to type 2 diabetes. In the Finnish Diabetes Prevention Study, individuals with the G-250G genotype had a higher conversion rate to type 2 diabetes compared to those with the -250A allele. This suggests that genetic factors, particularly those regulating lipid and lipoprotein metabolism, are significant in the progression to type 2 diabetes.
Blood sugar levels above 250 mg/100 ml are associated with various health risks, including vascular damage and hypertension. Dietary interventions alone may not suffice in managing high blood sugar levels, and genetic factors play a crucial role in the progression to diabetes. Natural remedies like Swertia chirayita show promise in lowering blood sugar levels, while the insulin response in premature infants highlights the need for tailored nutritional strategies. Understanding these factors is essential for effective management and prevention of diabetes and related complications.
Most relevant research papers on this topic